UH
Uwe Hurth
Active Director Director DIN 07900128
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value •••• Premium profile
About Uwe Hurth
Data last updated:
Uwe Hurth is a Director at Ursapharm India Private Limited (since 2017). The company operates in Pharma. Ursapharm India Private Limited reported revenue of ₹6.22 Cr (FY 2024).
DIN 07900128
Primary Designation Director
Industry Pharma
First Appointment 05 Dec 2017
Oldest Company Age 20 yrs
Largest company Ursapharm India Private Limited · ₹6.22 Cr (FY 2024)
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ursapharm India Private Limited U24232DL2006FTC154392 | Director | 05 Dec 2017 | 2006 | ₹6.22 Cr (FY 2024) | Active |
Board colleagues of Uwe Hurth
| Name | DIN | Company | Designation |
|---|---|---|---|
| Boris Georg Roeder | 02232274 | Ursapharm India Private Limited | Director |
| Rohit Jain | 00247796 | Ursapharm India Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Ursapharm India Private Limited
Premium access
Shareholding and investment profile for Uwe Hurth
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Uwe Hurth
Uwe Hurth currently holds 1 directorship: Ursapharm India Private Limited (Director, since 05 Dec 2017, revenue ₹6.22 Cr (FY 2024)).
Uwe Hurth was first appointed on 05 Dec 2017 as Director at Ursapharm India Private Limited.
The current boards of Uwe Hurth's companies include Boris Georg Roeder (Ursapharm India Private Limited), Rohit Jain (Ursapharm India Private Limited).